Analyst consensus rating
RxSight Analyst Rating: Hold
Direct answer
RxSight's consensus rating is Hold.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.57.
Forecast evidence checked October 17, 2026.
Get free RxSight email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.51
- Average price target
- $7.57
- High price target
- $11.00
- Low price target
- $5.50
- Low target gap
- +22%
- Target upside
- +67.8%
- High target gap
- +143.9%
- Target range width
- 122%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for RxSight?
RxSight has a verified Hold consensus. The same dataset has an average price target of $7.57.
How far are RxSight's low and high targets from the recorded price?
The low target implies +22%, while the high target implies +143.9%.
How many analysts are included in RxSight's consensus?
The verified consensus includes 8 analysts.
How is RxSight's target upside or downside calculated?
The average target of $7.57 is divided by the recorded price of $4.51, then one is subtracted to produce +67.8%. This does not guarantee a future return.
When was RxSight's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.